ENDRA Life Sciences ROE 2017-2025 | NDRA
Current and historical return on equity (ROE) values for ENDRA Life Sciences (NDRA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ENDRA Life Sciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $-0.01B | $0.00B | -246.15% |
| 2025-03-31 | $-0.01B | $0.00B | -171.43% |
| 2024-12-31 | $-0.01B | $0.00B | -191.30% |
| 2024-09-30 | $-0.01B | $0.01B | -123.08% |
| 2024-06-30 | $-0.01B | $0.01B | -150.00% |
| 2024-03-31 | $-0.01B | $0.00B | -181.82% |
| 2023-12-31 | $-0.01B | $0.01B | -181.82% |
| 2023-09-30 | $-0.01B | $0.01B | -208.70% |
| 2023-06-30 | $-0.01B | $0.01B | -171.43% |
| 2023-03-31 | $-0.01B | $0.00B | -152.94% |
| 2022-12-31 | $-0.01B | $0.01B | -133.33% |
| 2022-09-30 | $-0.01B | $0.01B | -120.93% |
| 2022-06-30 | $-0.01B | $0.01B | -113.04% |
| 2022-03-31 | $-0.01B | $0.01B | -100.00% |
| 2021-12-31 | $-0.01B | $0.01B | -77.19% |
| 2021-09-30 | $-0.01B | $0.01B | -75.47% |
| 2021-06-30 | $-0.01B | $0.02B | -102.33% |
| 2021-03-31 | $-0.01B | $0.02B | -151.72% |
| 2020-12-31 | $-0.01B | $0.01B | -342.86% |
| 2020-09-30 | $-0.02B | $0.00B | -633.33% |
| 2020-06-30 | $-0.02B | $0.00B | -720.00% |
| 2020-03-31 | $-0.02B | $0.00B | -618.18% |
| 2019-12-31 | $-0.02B | $0.01B | -566.67% |
| 2019-09-30 | $-0.01B | $0.00B | -307.69% |
| 2019-06-30 | $-0.01B | $0.00B | -333.33% |
| 2019-03-31 | $-0.01B | $0.00B | -333.33% |
| 2018-12-31 | $-0.01B | $0.01B | -363.64% |
| 2018-09-30 | $-0.01B | $0.00B | -400.00% |
| 2018-06-30 | $-0.01B | $0.00B | -188.24% |
| 2018-03-31 | $-0.01B | $0.00B | -121.74% |
| 2017-12-31 | $-0.01B | $0.01B | -105.26% |
| 2017-09-30 | $0.00B | $0.01B | -123.08% |
| 2017-06-30 | $0.00B | $0.01B | -266.67% |
| 2017-03-31 | $0.00B | $0.00B | 800.00% |
| 2016-12-31 | $0.00B | $0.00B | 1200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.004B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.267B | 25.34 |
| Intuitive Surgical (ISRG) | United States | $196.642B | 76.93 |
| IDEXX Laboratories (IDXX) | United States | $57.510B | 57.11 |
| Edwards Lifesciences (EW) | United States | $48.635B | 32.23 |
| Alcon (ALC) | Switzerland | $36.668B | 24.62 |
| IQVIA Holdings (IQV) | United States | $35.783B | 19.95 |
| Mettler-Toledo (MTD) | United States | $29.657B | 35.20 |
| STERIS (STE) | Ireland | $23.951B | 24.64 |
| DexCom (DXCM) | United States | $23.120B | 31.87 |
| Waters (WAT) | United States | $22.145B | 29.29 |
| Hologic (HOLX) | United States | $16.510B | 17.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.063B | 0.00 |
| Penumbra (PEN) | United States | $8.796B | 62.13 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Masimo (MASI) | United States | $7.635B | 24.47 |
| Sysmex ADR (SSMXY) | Japan | $6.484B | 20.60 |
| Teleflex (TFX) | United States | $5.513B | 8.90 |
| Glaukos (GKOS) | United States | $4.845B | 0.00 |
| TransMedics (TMDX) | United States | $4.253B | 50.39 |
| Veracyte (VCYT) | United States | $3.622B | 41.48 |
| Alphatec Holdings (ATEC) | United States | $2.929B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.774B | 14.99 |
| Integer Holdings (ITGR) | United States | $2.388B | 11.21 |
| Artivion (AORT) | United States | $2.195B | 110.74 |
| Nihon Kohden (NHNKY) | Japan | $1.980B | 23.63 |
| PROCEPT BioRobotics (PRCT) | United States | $1.759B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.736B | 16.82 |
| Beta Bionics (BBNX) | United States | $1.167B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.095B | 0.00 |
| IRadimed (IRMD) | United States | $1.081B | 51.49 |
| AxoGen (AXGN) | United States | $1.078B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.888B | 4.81 |
| SiBone (SIBN) | United States | $0.663B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.541B | 31.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.495B | 9.87 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.435B | 3.42 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 10.38 |
| Treace Medical Concepts (TMCI) | United States | $0.395B | 0.00 |
| RxSight (RXST) | United States | $0.341B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.336B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 51.06 |
| Spectral Diagnostics (EDTXF) | Canada | $0.292B | 0.00 |
| 908 Devices (MASS) | United States | $0.290B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.263B | 0.00 |
| CVRx (CVRX) | United States | $0.256B | 0.00 |
| Inogen (INGN) | United States | $0.200B | 0.00 |
| Neuronetics (STIM) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Hyperfine (HYPR) | United States | $0.089B | 0.00 |
| InspireMD (NSPR) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.080B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.66 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |